WASHINGTON D.C. — A groundbreaking study released today confirms what most health professionals already suspected: if a new drug promises rapid weight loss, Americans will enthusiastically inject, ingest, or otherwise administer it, regulatory approval be damned. The research, conducted by the Institute for Aspirational Proximity Studies, found a staggering 94% of adults would, given the opportunity, bypass the U.S. Food and Drug Administration's 'tedious and frankly fat-phobic' testing protocols for any substance rumored to be a 'game-changer' in the quest for a smaller waistline.
The study focused on the surging demand for Retatrutide, an unapproved weight loss compound currently in clinical trials. Despite explicit warnings from medical experts about unknown side effects, potential organ damage, or simply 'not doing anything useful at all,' a significant portion of respondents expressed a willingness to source the drug from 'underground wellness networks,' 'discreet Telegram channels,' or even 'that one guy at the gym.'
“Look, the FDA is, like, super slow. My body needs to be snatched *now* for Coachella, not in 2028,” explained Chantel, 28, a content creator known for her ‘Glow Up Grindset’ series, who proudly displayed her latest subcutaneous injection via TikTok Live. “This isn't reckless; it's proactive self-care. My mental health can’t wait for Big Pharma to finish their 'phases' or whatever. My followers demand results.”
Dr. Anya Sharma, head of the 'Department of Realistic Expectations' at the Institute, expressed exasperation. “We try to explain things like liver damage, cardiac events, or even just 'this might not work,' but it seems the promise of a smaller waistline is a more compelling narrative than basic human physiology. Our data suggests a solid 37% of respondents would consider a drug administered by a shaman in a darkened alley if it trended on Instagram.”
One anonymous online pharmacist, operating from a discreet Telegram channel, stated, “Our clients aren't waiting for some bureaucratic approval. They're empowered consumers making informed choices — mostly based on what their favorite influencer is shilling. We just facilitate freedom, at a slight markup for expedited 'research access.'” When pressed about potential adverse reactions, the pharmacist added, “Look, if it kills them, at least they died skinny. What’s the worst that could happen? They don't look good in their coffin?”
Ultimately, experts continue to warn against potential long-term health consequences from unregulated substances, but most users reported they’d “cross that bridge when they’re finally hot enough to get to it.”
